Treatment-refractory Cancers

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-12-03
Clinical Trial Update: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers [Phase 1]
Phase 1 trial evaluating the safety and potential activity of recombinant interleukin-15 in combination with nivolumab and ipilimumab in pat…